The global breast cancer imaging market size was valued USD 3.6 billion in 2020 and is anticipated to register at a robust CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the improved quality of breast images, patient comfort, and reduced patient dose.
Breast cancer imaging system is a diagnostic tool utilized for locating the site of cancer cells. It provides detailed information such as extent of the disease as well as the structural changes. Cancer imaging systems detect the tumor in the body and its associated complications, which helps in the evaluation of the post therapeutic treatment by specialists.
Breast cancer imaging is also used to evaluate the stages. Mammography, ultrasonography, and breast magnetic resonance imaging (MRI) are three types of imaging systems that are used for detection of breast cancer.
The report on the global breast cancer imaging market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes | Details |
Report Title | Breast Cancer Imaging Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year | 2020 |
Historic Data | 2018–2019 |
Forecast Period | 2021–2028 |
Segmentation | Types of Imaging Techniques (Mammography, Breast Ultrasound, Breast MRI, Image-guided breast biopsy, and Others), End-users (Hospitals, Diagnostic Centers, and Others) |
Regional Scope | Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report | General Medical Merate S.p.A., Aurora Health Care, CMR Naviscan Corporation, SonoCine, Inc., and Dilon Technologies, Inc |
Based on types of imaging techniques, the market is divided into mammography, breast ultrasound, breast MRI, image-guided breast biopsy, and others. The mammography segment is expected to represent a major market share during the forecast period. Rising initiatives taken to increase the awareness about the breast cancer is expected to propel the market growth. Mammography is the standard technique used to screen breast cancer in government and private healthcare hospitals. Government state bodies across the globe are taking initiatives to provide treatment for women between the age 50 and 75, spurring the segment growth.
In terms of end-users, the market is segmented into hospitals, diagnostic centers, and others. The hospitals segment is anticipated to register a substantial CAGR during the forecast period. Increasing healthcare infrastructure development, higher purchasing power, and availability of well-equipped operating & diagnostic rooms, and better health coverage for healthcare services are expected to proliferate the segment growth.
On the basis of regions, the market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market during the forecast period. The regional market growth can be attributed to the growing burden of breast cancer coupled with advancement in healthcare infrastructure and rising healthcare expenditure.
Segments Covered in the Report
The global breast cancer imaging market has been segmented on the basis of
Types of Imaging Techniques
End-users
Regions
Key Players
Key players competing in the breast cancer imaging market include General Medical Merate S.p.A., Aurora Health Care, CMR Naviscan Corporation, SonoCine, Inc., and Dilon Technologies, Inc.
Segments Covered in the Report
The global breast cancer imaging market has been segmented on the basis of
Types of Imaging Techniques
End-users
Regions
Key Players
Key players competing in the breast cancer imaging market include General Medical Merate S.p.A., Aurora Health Care, CMR Naviscan Corporation, SonoCine, Inc., and Dilon Technologies, Inc.
Some other reports from this category!